ライフサイエンスコーパス: IV

1 IV acetaminophen thus produces modest fever reduction in

2 IV exposure to the inert ingredients in reformulated ext

3 IV immunoglobulins were infused (IV immunoglobulin) duri

4 IV infusion of 1, 2, 3, or 4 mL/Kg (body weight) of crys

5 IV treatment with HPssCD-HET0016 decreased tumor growth,

6 +/- 0.9 y; GMFCS: I, 48%; II, 11%; III, 15%; IV, 11%; and V, 15%).

7 We demonstrate that the Co(III)2(IV)2 cubane may be electrochemically generated and the e

8 ur understanding of the Chlamydomonas CCM 58 IV.

9 GeSe is a IV-VI semiconductor, like the excellent thermoelectric m

10 NC1 domain from the collagen alpha3(IV) chain was cloned into a mammalian expression vector,

11 that NC1 domain derived from collagen alpha3(IV) chain-a major structural component of the BM-was cap

12 Using health-care provider preference as an IV method, we propose a 2-step procedure with which to e

13 2139 to -1958), III (bp -1879 to -1799), and IV (bp -6200 to -5670).

14 stratum corneum lipid architecture in AD and IV HEEs, independent of FLG genotype.

15 Genes encoding types I and IV pili, quorum sensing components, and proteins involve

16 nsport) proteins and found that ESCRT II and IV significantly control exosome release.

17 constant, mitochondrial complexes I, II, and IV and respiratory responses were defective in vitiligo

18 and preferentially occurred in stage III and IV tumors.

19 y established PRETEXT groups I, II, III, and IV as our stems, we created risk stratification trees ba

20 n enzyme deficiency of complexes I, III, and IV.

21 ulations of the electromagnetic, thermal and IV characteristics of the device have been performed.

22 Both AD (FLG/WT) and IV (FLG/FLG) HEEs showed impaired late epidermal differe

23 onium element able to exhibit both +III and +IV oxidation states in solution, but evidence of a stabl

24 ectively blocking the effects of angiotensin IV (AngIV) at its receptor (AT4R) with divalinal in mice

25 and cargoes, including apolipoproteins ApoA-IV and ApoC-II, contributing to VLDL/HDL distribution an

26 uced and that the estrogenic effects on apoA-IV gene expression and food intake are impaired.

27 of SRC-1 in E2's stimulatory effect on apoA-IV gene expression.

28 -fat diet-induced obese (DIO) rats, the apoA-IV mRNA level is significantly reduced and that the estr

29 SRC-1 is colocalized with apoA-IV in the cells of the NTS and E2 treatment enhances the

30 Because of the presence in area IV of binding sites for transcription factors associated

31 In HF, Astragaloside IV switched glycolysis to fatty acid beta-oxidation, as

32 te (FOS) on the carbon remains unchanged at -IV relative to that in methane.

33 Bk(III)-O and Bk(IV)-O bond lengths are shorter than anticipated and prov

34 This neutral Bk(IV) coordination compound is not sequestered by the prot

35 0 d) causes oxidation of Bk(III) and only Bk(IV) is present after a few days with concomitant loss of

36 Older age, white race, lower BMI, IV drug use, lower baseline CD4, HCV coinfection, prior

37 of PFOA in rats following exposure via both IV and oral routes.

38 nds, among which 19 of them belong to TRIM C-IV subgroup.

39 pported, terminal multiple bond between a Ce(IV) ion and a ligand fragment was also isolated by encap

40 idly and easily cycle between Ce(III) and Ce(IV) oxidation states, making them prime candidates for c

41 gands but also an unusual, direct Mn(III)-Ce(IV)-Mn(III) metal-to-metal channel involving the Ce(IV)

42 hic characterization of [(N4Py)Fe(III) -O-Ce(IV) (OH2 )(NO3 )4 ](+) (3), a complex obtained from the

43 Ceric ammonium nitrate (CAN) or Ce(IV) (NH4 )2 (NO3 )6 is often used in artificial water ox

44 III) metal-to-metal channel involving the Ce(IV) f orbitals.Perovskite manganites exhibit intriguing

45 and rhodamine B (Ce-RB), and acidic cerium (IV) and rhodamine 6G (Ce-R6G) enhanced by SDS) for the d

46 by formaldehyde (KMnO4-COH), acidic cerium (IV) and rhodamine B (Ce-RB), and acidic cerium (IV) and

47 er incubation experiments suggest that Clade IV populations may harbour stress-tolerant subgroups, an

48 alifornia Bight populations, while the Clade IV representative downregulated Fe-limitation proteins.

49 American Society of Anesthesiologists class IV (7426 patients [32.6%] vs 15 683 [23.3%] for the infr

50 dered among New York Heart Association class IV (NYHA IV) heart failure patients.

51 al class III: 28%; and NYHA functional class IV: 4%).

52 pentaplegic (Dpp), specifically in the Class IV multidendritic nociceptive neuron, significantly atte

53 ied (swine H1-gamma, H1-beta, and H3-cluster-IV IAVs) and co-circulated at different proportions over

54 nd strong credence to the intermediacy of Co(IV)-O species in cobalt-catalysed oxidation of organic s

55 entified basement membrane (BM) and collagen IV in Ctenophora, and show that the structural and genom

56 ironment, and as a component of BM, collagen IV enabled the assembly of a fundamental architectural u

57 l requirements of LOXL2 that enable collagen IV crosslinking.

58 structural and genomic features of collagen IV are homologous to those of non-bilaterian animal phyl

59 ructure and composition in terms of collagen IV, laminin, and fibronectin.

60 mbinant laminins, with retention of collagen IV, reiterating the basement membrane (BM) changes obser

61 Collectively, we conclude that collagen IV and its variant, spongin, are primordial components o

62 plement NRS to detect gentamicin, a commonly IV-administered antibiotic and EC-SERS to detect dobutam

63 ate 3 respiratory activity, impaired complex IV function, and mitochondrial swollen morphology in the

64 nd results in the destabilization of complex IV and alteration of its enzymatic properties.

65 tric component, i.e. as a subunit of complex IV, to support its activity.

66 ntin had no effect on complex II- or complex IV-mediated respiration.

67 Within the non-Lactobacillus-dominant CST IV, GBS positive status was significantly more prevalent

68 atus was significantly more prevalent in CST IV-A than CST IV-B.

69 ficantly more prevalent in CST IV-A than CST IV-B.

70 II) and Cys(II)-Cys(IV)), ribbon (Cys(I)-Cys(IV) and Cys(II)-Cys(III)), or bead (Cys(I)-Cys(II) and C

71 s: globular (Cys(I)-Cys(III) and Cys(II)-Cys(IV)), ribbon (Cys(I)-Cys(IV) and Cys(II)-Cys(III)), or b

72 )), or bead (Cys(I)-Cys(II) and Cys(III)-Cys(IV)).

73 and electrochemical SERS (EC-SERS) to detect IV therapy analytes within their clinically relevant ran

74 DPP-IV inhibitory peptide sequences identified within camel

75 Nine novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides (FLQY, FQLGASPY, ILDKEGIDY, ILEL

76 Camel milk proteins contain novel DPP-IV inhibitory peptides which may play a role in the regu

77 ure and time had a significant effect on DPP-IV inhibitory properties (p<0.05) in contrast with E:S (

78 Several peptides with DPP-IV inhibitory features or known activity were identified

79 s (aged 11-17 years) with a diagnosis of DSM IV major depressive disorder were randomly assigned (1:1

80 DSM-IV (Diagnostic and Statistical Manual of Mental Disorder

81 in non-psychiatric controls (CON, N=29), DSM-IV major depressive disorder suicides (MDD-S, N=21) and

82 nth alcohol use, high-risk drinking, and DSM-IV AUD.

83 ubjects organized by Biotype and then by DSM-IV-TR diagnosis (n = 1409) using voxel-based morphometry

84 ms (21%, 20-23), whereas the most common DSM-IV-oriented scale was anxiety problems (13%, 12-14).

85 nd the Structured Clinical Interview for DSM-IV evaluated MDD.

86 We also assessed 14 lifetime DSM-IV mood, anxiety, disruptive behavior and substance diso

87 iteria for bipolar disorder, and 310 met DSM-IV criteria for a manic or hypomanic episode.

88 All 4,360 participants met DSM-IV criteria for bipolar disorder, and 310 met DSM-IV cri

89 Youths who met DSM-IV criteria for full or probable diagnoses of separation

90 gnoses of MDD and subtypes were based on DSM-IV symptoms.

91 with an acute manic or mixed episode per DSM-IV-TR criteria were enrolled in this randomized, placebo

92 The results were similar for the DSM-IV symptom count at follow-up.

93 Neuropsychiatry Interview, according to DSM-IV criteria.

94 and the secondary outcome was the total DSM-IV MDD symptom score.

95 METHOD: Patients with DSM-IV hypochondriasis (N=195) were randomly assigned to one

96 Youths aged 7-17 years with DSM-IV OCD and typically developing controls underwent 3 T p

97 ute Physiology and Chronic Health Evaluation IV scores did not differ significantly (82 [75-98] vs 76

98 ectron reduction-protonation of [(DCHIm)F8Fe(IV) horizontal lineO] occurs faster (ket2 = 5.0 M(-1) s(

99 e intermediacy of a high-valent [(DCHIm)F8Fe(IV) horizontal lineO] species is thus implied, and separ

100 The pi-trajectory for H atom abstraction (Fe(IV) horizontal lineO oriented perpendicular to the C-H b

101 mediate reactivity is typically found for Fe(IV)Fe(IV); therefore, kinetic features for these species

102 e reactivity is typically found for Fe(IV)Fe(IV); therefore, kinetic features for these species in in

103 in, we assess the structure of the Mn(IV)/Fe(IV) activation intermediate using Fe- and Mn-edge extend

104 I) (NCMe)](2+) with 2 equiv CAN or [(N4Py)Fe(IV) =O](2+) (2) with Ce(III) (NO3 )3 in MeCN.

105 This observation suggests that Fe(IV) =O complexes may avail of reaction pathways involvin

106 terest is the effect of spin state of the Fe(IV)(O) unit.

107 ring an equatorial N-donor ligand, [L(TMC)Fe(IV)(O) (MeCN)](2+) (A), the tetracarbene complex 1 is si

108 A combined genetic IV expected to confer a lifetime exposure of 5-kg/m2 hig

109 ted by N-acetylglucosaminyltransferase (GnT)-IV, is a good substrate for FUT8, but the A3(2,2,6) type

110 he growth of intractable glioblastoma (grade IV glioma) and glioma stem cells (GSCs).

111 edure, including three with a previous grade IV HSR.

112 (WHO grade III) and glioblastoma (WHO grade IV) showed decreased OEF when compared with normal brain

113 e demonstrate a low-threshold, compact group IV laser that employs a germanium nanowire under a 1.6%

114 ts Of 54 eyes, 42 were Reese-Ellsworth group IV to V, and 37 were International Classification of Ret

115 Children in GMFCS group IV were lighter-for-age, and children in GMFCS group V h

116 integration of efficient, miniaturized group IV lasers into CMOS architecture holds the key to the re

117 ctroscopic measurements show that when group IV (i.e., Ti, Zr, and Hf) or V (i.e., Nb and Ta) transit

118 tabilises the native conformation of EF-hand IV, leading to a transient unfolding and dissociation of

119 care, receipt of nephrotoxins, and hospital, IV vancomycin plus piperacillin/tazobactam combination t

120 tochondrial phospholipidome and complexes I, IV, and V activities.

121 also known as Esp1) contains four domains (I-IV), and a substrate-binding domain immediately precedes

122 This paradigm was then used in layers I-IV of slices of the rat motor cortex to determine the pe

123 mitochondrial complex cytochrome c oxidase I/IV and lower ATP levels.

124 Gravis Foundation of America (MGFA) class II-IV disease, vaccination against Neisseria meningitides,

125 ge (IA, IB, and IIA) and advanced stage (IIB-IV) with bulky disease.

126 accommodated between helices III/IV and III'/IV'.

127 < .001; HR, 5.96, P < .001, for classes III, IV, and V vs II, respectively), age (HR, 1.02, P = .001)

128 A I-II) to &OV0556;2515 (>/=75 years ASA III-IV).

129 alysis, New York Heart Association class III/IV, RVESRI, and log NT-proBNP (N-Terminal Pro-B-Type Nat

130 eptides are accommodated between helices III/IV and III'/IV'.

131 Cr(III) silicates or (hydr)oxides and Mn(III/IV) oxides-that lead to its production.

132 wo-state reactivity model, and 2) the Mn(III/IV) reduction potentials.

133 -minerals are colocated with biogenic Mn(III/IV)-oxides, suggesting Cr(VI) generation through oxidati

134 IV immunoglobulins were infused (IV immunoglobulin) during 15 episodes (25.4%).

135 jury via endotracheal (ET) or intravascular (IV) administration.

136 following single oral (PO) and intravenous (IV) administration to cockatiels (Nymphicus hollandicus)

137 red either subcutaneously or by intravenous (IV) infusion and to assess the pharmacokinetics and in v

138 , we have generated an improved intravenous (IV) formulation of HET0016 with HPssCD and tested in ani

139 d to free doxorubicin, a single intravenous (IV) administration of CP-Dox at the maximum tolerated do

140 de into the CSF compared to the intravenous (IV) route, which requires blood-brain barrier penetratio

141 An intravenously (IV) administered calcimimetic could improve adherence an

142 nical features of 3 patients and investigate IV exposure to the tablet's inert ingredients as a possi

143 s in the formation of fully characterized Ir(IV,V) and Ir(III,III) complexes.

144 ion or reduction of our recently reported Ir(IV,IV) mono-mu-oxo dimers results in the formation of fu

145 y shows reversible conversion between the Ir(IV,V) and proposed Ir(V,V) species without any degradati

146 mpared with a topologically related oxo-iron(IV) complex bearing an equatorial N-donor ligand, [L(TMC

147 auer experiments identified a transient iron(IV)-oxo (ferryl) complex.

148 ion and compare reactivities of various iron(IV)-oxo complexes generated as dications or monocations

149 (n = 12 each) received three 10 or 30 mg/kg IV VRC01 doses every 8 weeks, respectively.

150 ry and higher-order auditory fields in layer IV and infragranular layers.

151 nsfusions (IUPT), as well as weekly maternal IV immunoglobulin infusion (IVIG), with or without addit

152 eived 28-day cycles of pembrolizumab, 200 mg IV every 2 weeks, pomalidomide 4 mg daily for 21 days, a

153 Whereas ML-IV patients are reportedly achlorhydric, transgenic over

154 SOD activity in the presence of (*)OH and Mn(IV)-oxo species by channeling these oxidants toward the

155 the valence assignment of the cubane as [Mn(IV)Co(III)3].

156 have synthesized and characterized a rare Mn(IV)-NCO intermediate and demonstrated its ability to tra

157 utilize conductive "nanowires" to reduce Mn(IV) and Fe(III) oxides in anaerobic sediments.

158 currently known if and to what extent the Mn(IV) and Fe(III) oxides in soil grains and low permeabili

159 show that the oxygen atoms present in the Mn(IV) dimers originate from O2 .

160 parates Geobacter sulfurreducens from the Mn(IV) mineral birnessite by a 1.4 mum thick wall containin

161 Herein, we assess the structure of the Mn(IV)/Fe(IV) activation intermediate using Fe- and Mn-edge

162 For these Mn(IV) -oxo complexes, the rate enhancements are correlated

163 ulations, evidence is provided that these Mn(IV) species comproportionate with a Mn(II) precursor to

164 en the formal Mo(VI) horizontal lineS and Mo(IV)-SH states, and by modeling chronoamperometry data re

165 of polyanionic trimeric units of molybdenum(IV).

166 n the in vitro growth study, MOS-III and MOS-IV was found to be effective in selectively promoting th

167 the isolated mannan oligomers, MOS-III, MOS-IV, MOS-V and MOS-VI consist of tetra-, penta-, hexa-, a

168 otif VI, as well as the Dut conserved motifs IV and V.

169 ng New York Heart Association class IV (NYHA IV) heart failure patients.

170 Coadministration of IV vancomycin and piperacillin/tazobactam may increase t

171 For adults, the combination of IV vancomycin plus piperacillin sodium/tazobactam sodium

172 To determine the effects of IV acetaminophen on core body temperature, blood pressur

173 l physicians should be highly inquisitive of IV drug abuse when presented with cases of TMA.

174 e sepsis, including a minimum of 30 mL/kg of IV fluids, infectious workup including blood cultures, b

175 rature addressing the efficacy and safety of IV iron in pregnancy are reviewed.

176 Patient was started on IV fluids and antibiotics.

177 w York Heart Association (NYHA) class III or IV at baseline.

178 2 patients, and 28 patients had stage III or IV disease.

179 are therefore classified as WHO grade III or IV high-grade gliomas (HGGs).

180 meta-analysis was conducted of phase III or IV randomized trials of potent P2Y12 inhibitors, includi

181 om high-grade glioma (HGG) (WHO grade III or IV).

182 d with late-stage disease (AJCC stage III or IV).

183 e of New York Heart Association class III or IV, confirmed by a cardiologist, and a significant LVEF

184 rk Heart Association Functional Class III or IV, previous admission for heart failure, and valve dise

185 diethyllead (DEL) is a substrate and the Pb(IV) product remains bound in the active site.

186 Thus, Pb(IV) ions are especially prone to interact with Abeta and

187 While Pb(IV) ions affected mainly Abeta dimer and trimer formatio

188 manifolds, including Pd(0)/Pd(II), Pd(II)/Pd(IV), and Pd(II)/Pd(0).

189 Nine novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides (FLQY, FQLGASPY, ILDKEGI

190 variants, for example, dipeptidyl peptidase-IV inhibitor-associated noninflammatory bullous pemphigo

191 Phase IV, multicenter, open-label extension study.

192 TMA-like state also developed in guinea pigs IV administered PEO+.

193 hotoactivatable dopamine-conjugated platinum(IV) anticancer complex (Pt-DA) has been incorporated int

194 In contrast to the parent platinum(IV) complex, the in situ generated platinum(II) complex

195 Plutonium(IV) is one example of a species which displays significa

196 h the translesion polymerases Pol II and Pol IV.

197 anges in the non-coding RNAs produced by Pol IV and Pol V.

198 factors: PRETEXT I/II, PRETEXT III, PRETEXT IV, metastatic disease, and AFP concentration of 100 ng/

199 A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect

200 does not cross-react with satraplatin, a Pt(IV) prodrug.

201 via highly efficient and stereoselective Pt(IV)-catalyzed cycloaddition reactions of the correspondi

202 d are benchmarked by the pure Pu(III) and Pu(IV) dipicolinate complexes, [Pu(III)(DPA)(H2O)4]Br and P

203 ate complexes, [Pu(III)(DPA)(H2O)4]Br and Pu(IV)(DPA)2(H2O)3.3H2O, as well as by a second mixed-valen

204 ic Pu colloid is influenced by hydrolysed Pu(IV) species to a greater extent than in sonochemical PuO

205 -stoichiometric PuO2 cores and hydrolyzed Pu(IV) moieties at the surface shell.

206 y a second mixed-valent compound, Pu(III)[Pu(IV)(DPA)3H0.5]2, that falls into class I instead.

207 ighly soluble Pu(V,VI) to the less mobile Pu(IV) within the argillaceous rock material, while bulk in

208 ical water splitting enables reduction of Pu(IV) to more soluble Pu(III), which then re-oxidizes yiel

209 Pu(III), which then re-oxidizes yielding Pu(IV) colloid.

210 Studies in which human subjects received IV angiotensin II were selected whether or not safety wa

211 hospitalized for 3 or more days who received IV vancomycin plus 1 other antipseudomonal beta-lactam c

212 cate measurements of 14 and 35microgL(-1) Se(IV), respectively.

213 id (IL) was applied for the extraction of Se(IV)-ammonium pyrrolidine dithiocarbamate (APDC) complex

214 E) method was developed for inorganic Se [Se(IV) and Se(VI)] speciation analysis in Allium and Brassi

215 Serotype IV accounted for 6% of the colonizing isolates, a rate c

216 considered to be the main driver of serotype IV GBS expansion in North America.

217 The majority of serotype IV isolates belonged to sequence type (ST)459, a tetracy

218 Seven silicon(IV) phthalocyanine carboxylate esters (SiPcs, 1-7) with

219 rrelates most strongly with venous and small IV intimal thickening, similar to the pattern observed i

220 xtract the bound Pb(VI) but not the bound Sn(IV).

221 Noting that the two sites for ST8Sia-IV autopolysialylation flank the PBR, we evaluated the r

222 Finally, we found that ST8Sia-IV autopolysialylation is required for NRP-2 polysialyla

223 20.2%) as stage III, and 165 (5.0%) as stage IV.

224 years), 65.3% were male, and 81.3% had stage IV disease at the time of genomic analysis, with prostat

225 Predictors of worse survival included stage IV disease (HR, 1.40; 95% CI, 1.24-1.58), decompensated

226 b due to metastatic cutaneous melanoma stage IV.

227 ally confirmed recurrent stage IIIb or stage IV, chemotherapy-naive NSCLC.

228 e hazard ratio comparing patients with stage IV versus stage I LA LGE was 1.67 (95% confidence interv

229 ollowing current clinical protocol for Stage-IV PDAC suggests that unresponsive lesions may be growth

230 ce and isoflurane, and 322 received standard IV sedation.

231 ion in the form of poorly soluble hydrous Tc(IV)-oxides or Tc(IV)-sulfides during the development of

232 Incorporation of Tc(IV) has little effect on the spinel lattice structure.

233 f poorly soluble hydrous Tc(IV)-oxides or Tc(IV)-sulfides during the development of reducing conditio

234 ostimulation and the stability of reduced Tc(IV) phases under oxic conditions.

235 mobilization and were more resistant than Tc(IV) produced via biostimulation with an acetate/lactate

236 s oxidized and has a FOS less negative than -IV.

237 CI: 356, 494) were achieved 1 hour after the IV infusion series of 30 mg/kg and 10 mg/kg doses, respe

238 a test of mediation was performed using the IV.

239 Midazolam via the IV route with or without oral route is the drug of choic

240 Hierarchically assembled dinuclear titanium(IV) helicates represent a rare example in which the dire

241 f detected cells in ET injection compared to IV and a slight increase in the mean number of detected

242 e in Fitzpatrick skin types V to VI and I to IV, with minimal erythemal doses to monochromatic UV-B,

243 Grade II to IV acute graft-versus-host disease related to steroid tr

244 searched ClinicalTrials.gov for phase II to IV cancer trials of Food and Drug Administration-approve

245 al analysis of 676 genes in 107 stages II to IV primary colorectal cancer, of which half had metastas

246 c HF, New York Heart Association class II to IV symptoms, and a left ventricular EF of 40% or less to

247 CI of acute graft-versus-host disease II to IV was 32.3% after RIC and 37.5% after MAC ( P = .35).

248 Acute GVHD, either grade III to IV (30 patients, 33%) or refractory (12 patients, 13%) h

249 e cellular decatenating enzyme topoisomerase IV interact.

250 vely supercoiled) DNA, whereas topoisomerase IV generated similar levels with both substrates.

251 Type IV pili (Tfp), which are key virulence factors in many b

252 Type IV REases tend to target modified DNA sites, and E. coli

253 A type IV functional response (i.e. dome-shaped relationship) o

254 esults provide the first structure of a type IV pilin protein involved in the formation of competence

255 adenine Recognition and Restriction), a Type IV restriction endonuclease (REase), as instigator for t

256 e remarkable structural diversity among type IV pilin proteins.

257 y consisting of mixtures of type II and type IV beta-turns.

258 e possible interaction between CLIC and type IV collagen, confirmed by protein structure prediction a

259 We previously observed a cutaneous type IV immune response in nonhuman primates (NHP) with the m

260 neuron loss and normal life expectancy (type IV).

261 also showed positive stain results for type IV collagen.

262 The protein complex responsible for type IV pilus assembly is homologous with the type II protein

263 08), or Fitzpatrick skin phototype (for type IV vs. type I, multivariable-adjusted RR = 0.99, 95% CI:

264 e envelope protein PilY1 and functional type IV pili are required mechanosensory elements.

265 elivered into host cells by the Dot/Icm type IV secretion system during infection.

266 encodes an ATPase homologue of type II/type IV systems.

267 to their biofilm-promoting function in type IV pili-producing heterotrophic bacteria.

268 ium/calmodulin-dependent protein kinase type IV (CaMKIV) is a key sensory/effector in excitatory syna

269 tations in TRPML1 lead to mucolipidosis type IV, a severe lysosomal storage disorder.

270 ysosomal storage disorder mucolipidosis type IV, and a gain-of-function mutation (Ala419Pro) in TRPML

271 gh the ComE pore through which the NTHI type IV pilus is expressed.

272 ic networks - one of laminin and one of type IV collagen (Figure 1, bottom).

273 icroscope analysis, the distribution of type IV collagen and effects of fibrosis on myocyte membrane

274 ction mutations are the direct cause of type IV mucolipidosis, an autosomal recessive lysosomal stora

275 escribed findings were dependent on the type IV secretion system (VirB) and the secreted BPE005 prote

276 omplex (TraC and TraG) with homology to type IV secretion-like systems.

277 secondary analysis of Fitzpatrick skin types IV, VI, and VI demonstrated a sustained interrater relia

278 method is capable to clearly characterize U(IV), U(V), and U(VI) existing simultaneously in the same

279 ediments accumulate U in its reduced form, U(IV), which is less mobile than oxidized U(VI).

280 e, degradable organic carbon, and geogenic U(IV) minerals.

281 We have investigated U(IV) accumulation in organic-enriched reduced sediments a

282 (IV) reoxidized, suggesting that monomeric U(IV) might have become incorporated in newly formed iron

283 r, little is known about the speciation of U(IV) in low-temperature geochemical environments, inhibit

284 Upon exposure to oxygen only part of U(IV) reoxidized, suggesting that monomeric U(IV) might ha

285 Yet a model of U(IV) speciation in the absence of mineral formation under

286 robic microbial respiration and stabilized U(IV).

287 Further, our data suggest that U(IV) can be mobilized under deeply reducing conditions, w

288 X-ray absorption spectra indicated that U(IV) in both hematite and lepidocrocite suspensions was n

289 ( approximately 58-89%) of U is bound as U((IV)) to C-containing organic functional groups or inorga

290 edominance of a relatively labile form of U((IV)) also provides an opportunity for a more economical

291 reaction at room temperature to form uranium(IV) siloxides.

292 ent of specific conditions, we suggest using IV hydrocortisone < 400 mg/day for >/= 3 days at full do

293 Instrumental variable (IV) methods provide unbiased treatment effect estimation

294 s (p < 5 * 10(-8)) as instrumental variable (IV).

295 s in the FLG gene cause ichthyosis vulgaris (IV) and represent the major predisposing genetic risk fa

296 icipants included at age 38 years, mean WAIS-IV score was 101.16 (14.82) and mean NZSEI-06 score was

297 1 patient with 2 lesions], WHO III: 17, WHO IV: 13, without biopsy low-grade: 1, high-grade: 1) were

298 s sedated with isoflurane when compared with IV sedation although no differences in neurologic outcom

299 ld-type AD (WT/WT), FLG-mutated AD (FLG/WT), IV (FLG/FLG), or FLG WT control skin, we assessed the po

300 s), ZrPP-n (n = 1, 2), featuring infinite Zr(IV) -oxo chains linked via polyphenolate groups on four